ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

PTN Palatin Technologies Inc New

1,827
0,107 (6,22%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Palatin Technologies Inc New PTN AMEX Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,107 6,22% 1,827 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,72 1,68 1,83 1,82 1,72
mais cotações »

Notícias Recentes

Data Hora Fonte Título
08/04/202408:30PRNUSPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
28/02/202409:30PRNUSPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
15/02/202409:30PRNUSPalatin Reports Second Quarter Fiscal Year 2024 Financial..
09/02/202409:30PRNUSPalatin to Report Second Quarter Fiscal Year 2024 Results;..
05/02/202409:30PRNUSPalatin Announces Database Lock for PL9643 MELODY-1 Pivotal..
01/02/202418:00PRNUSPalatin Announces Closing of $10 Million Registered Direct..
30/01/202410:00PRNUSPalatin Announces $10 Million Registered Direct Offering
08/01/202412:33PRNUSPalatin Provides Corporate Update and Highlights Strategic..
03/01/202410:00BWCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide..
20/12/202309:30PRNUSPalatin Completes Sale of Vyleesi® to Cosette..
18/12/202318:15PRNUSPalatin Receives Notice of Acceptance of the Listing..
14/11/202309:30PRNUSPalatin Reports First Quarter Fiscal Year 2024 Financial..
09/11/202309:30PRNUSPalatin to Report First Quarter Fiscal Year 2024 Results;..
24/10/202317:50PRNUSPalatin Announces Closing of $5 Million Registered Direct..
23/10/202308:30PRNUSPalatin Announces $5 Million Registered Direct Offering
19/10/202308:30PRNUSPalatin Announces Preliminary Quarter Ended September 30,..
18/10/202308:30PRNUSPalatin Announces Positive Preclinical Data Showing..
16/10/202308:30PRNUSPalatin Presents Data at the United European..
13/10/202317:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
28/09/202308:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2023..
22/09/202317:00PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2023..
07/09/202317:00PRNUSPalatin to Present at the H.C. Wainwright 25th Annual Global..
07/09/202308:30PRNUSPalatin Completes Enrollment in Phase 3 MELODY-1 Study of..
10/08/202308:30PRNUSPalatin Initiates Clinical Program for Bremelanotide..
08/08/202308:30PRNUSPalatin's Vyleesi® Licensee Fosun Pharma Reports First..
07/08/202308:30PRNUSPalatin Announces Direct-to-Consumer Telehealth Partnership..
04/08/202308:30PRNUSPalatin to Participate in Canaccord Genuity's 43rd Annual..
11/07/202308:30PRNUSPalatin Announces Preliminary Fourth Quarter Fiscal 2023..
30/05/202308:30PRNUSPalatin Presents Preclinical Diabetic Nephropathy Data at..
16/05/202308:30PRNUSPalatin Reports Third Quarter Fiscal Year 2023 Financial..
11/05/202317:15PRNUSPalatin to Report Third Quarter Fiscal Year 2023 Results;..
09/05/202308:30PRNUSPalatin Presents PL8177 Ulcerative Colitis Data at Digestive..
08/05/202317:04PRNUSPalatin Invites Investors to Listen to Replay of the PL9643..
01/05/202317:00PRNUSPalatin Technologies to Host Key Opinion Leader Webinar

Seu Histórico Recente

Delayed Upgrade Clock